Skip to main content
Clinical Trials/JPRN-jRCTs032210305
JPRN-jRCTs032210305
Completed
未知

Clinical outcomes in eyes with diffractive extended depth of focus intraocular lens enhanced for near vision: comparison with trifocal intraocular lens

Bissen Hiroko0 sites60 target enrollmentSeptember 13, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
Ocular disease
Sponsor
Bissen Hiroko
Enrollment
60
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

This study was aimed to examine differences in binocular visual acuity and contrast sensitivity after implantation of continuous-focus IOLs (Synergy) with those with trifocal IOLs. Although the superiority in binocular visual acuities at 30 cm and 40 cm, and binocular contrast sensitivities at far, 1 m, and 40 cm were denied, clinical characteristic of subjective IOLs in uncorrected binocular visual acuity and symptoms of dysphotopsia were clarified.

Registry
who.int
Start Date
September 13, 2021
End Date
August 23, 2022
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Bissen Hiroko

Eligibility Criteria

Inclusion Criteria

  • Patients who meet all of the following criteria are included in this study:
  • 1\) Patients who will undergo bilateral cataract surgery and are eligible for multifocal IOL implantation in both eyes.
  • 2\) Patients aged from 60 to 79 years.
  • 3\) Patients whose postoperative refractions are intended for emmetropia.

Exclusion Criteria

  • Patients who fall into any of the following criteria are excluded from participating in the study.
  • 1\) Patients with other ocular disease influencing visual function, such as uveitis, acute ocular disease, external/internal infection, diabetic retinopathy, glaucoma, exfoliation syndrome, pathological miosis, keratoconus, corneal endothelial dystrophy, and weak zonule.
  • 2\) Patients with history of intraocular or corneal surgery
  • 3\) Patients with other systemic or ophthalmic diseases considered to be unsuitable by an investigator.

Outcomes

Primary Outcomes

Not specified

Similar Trials